Small caps round-up: Infrastructure India, SkyePharma, LiDCO Group
Infrastructure India, an AIM-listed investment group, pleased its investors with a 50.2 per cent leap in its net asset value (NAV) to 207.3m pounds over the year ended March. The value of the company's investments rose 94.9 per cent to 216.7m pounds, while the NAV per share climbed from 92p to 95p. The company's Chairman said the period was one of "significant operating progress" in what has been a challenging period for investing in Indian infrastructure and stressed that it has diversified and increased the size of its portfolio.
Infrastructure India, an AIM-listed investment group, pleased its investors with a 50.2 per cent leap in its net asset value (NAV) to 207.3m pounds over the year ended March. The value of the company's investments rose 94.9 per cent to 216.7m pounds, while the NAV per share climbed from 92p to 95p. The company's Chairman said the period was one of "significant operating progress" in what has been a challenging period for investing in Indian infrastructure and stressed that it has diversified and increased the size of its portfolio.
Drug firm SkyePharma posted a strong rise in net profit after tax for the half year ended June 30th from £0.4m to £3.4m after research and development expenses fell from £10.1m to £6.3m and boosted by income from discontinued operations. Revenues were down 10%, in line with expectations, from £22.1m to £19.8m. Pre-exceptional earnings before interest, tax, depreciation and amortisation (EBITDA) from continuing operations were £4.9m (H1 2011: £4.2m). Cash at the end of the period fell £15.2m to £11.0m.
LiDCO Group, a cardiovascular monitoring company, expects its results for the six months to July 31st to show a four per cent increase in revenue at £3.3m, with cash at the period end at £1m. Product sales were up by 18%, while sales in the UK increased overall by 49%, with both LiDCO and Argon distributed product sales increasing well. Surgical disposables unit sales in the UK showed a significant and encouraging increase of 33%.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
NR
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.
-
What Santander’s takeover of TSB means for customers
Santander is set to buy rival TSB for £2.65 billion. What does it mean for customers, and could we see the TSB brand disappear from the high street?
-
How to find active fund managers that are worth paying for
Active funds are unlikely to beat a cheap tracker on average, but can be valuable in certain markets